Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment

被引:0
|
作者
Zhang, Xiaomeng [1 ]
Geng, Qi [1 ]
Lin, Lin [1 ]
Zhang, Lulu [1 ]
Shi, Changqi [1 ]
Liu, Bin [1 ]
Yan, Lan [1 ]
Cao, Zhiwen [1 ]
Li, Li [1 ]
Lu, Peipei [1 ]
Tan, Yong [1 ]
He, Xiaojuan [1 ]
Zhao, Ning [1 ]
Lu, Cheng [1 ]
机构
[1] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Drug-induced liver injury; Herb Induced Liver Injury; Hepatic microenvironment; Hepatotoxicity; Hepatocytes; KUPFFER CELLS; OXIDATIVE STRESS; STELLATE CELLS; T-CELLS; METHOTREXATE; HEPATOTOXICITY; ACTIVATION; TOXICITY; TRANSPORTERS; HEPATOCYTES;
D O I
10.1016/j.tox.2024.153900
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-Induced Liver Injury (DILI) and herb Induced Liver Injury (HILI) continues to pose a substantial challenge in both clinical practice and drug development, representing a grave threat to patient well-being. This comprehensive review introduces a novel perspective on DILI and HILI by thoroughly exploring the intricate microenvironment of the liver. The dynamic interplay among hepatocytes, sinusoidal endothelial cells, Kupffer cells, hepatic stellate cells, cholangiocytes, and the intricate vascular network assumes a central role in drug metabolism and detoxification. Significantly, this microenvironment is emerging as a critical determinant of susceptibility to DILI and HILI. The review delves into the multifaceted interactions within the liver microenvironment, providing valuable insights into the complex mechanisms that underlie DILI and HILI. Furthermore, we discuss potential strategies for mitigating drug-induced liver injury by targeting these influential factors, emphasizing their clinical relevance. By highlighting recent advances and future prospects, our aim is to shed light on the promising avenue of leveraging the liver microenvironment for the prevention and mitigation of DILI and HILI. This deeper understanding is crucial for advancing clinical practices and ensuring patient safety in the realm of DILI and HILI.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Drug-induced liver injury
    Denk, H
    PATHOLOGY OF THE KIDNEYS AND URINARY PASSAGES - MOLECULAR VASCULAR PATHOLOGY AND ANGIOGENESIS, 2002, 86 : 120 - 125
  • [42] Drug-Induced Liver Injury
    Leise, Michael D.
    Poterucha, John J.
    Talwalkar, Jayant A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (01) : 95 - 106
  • [43] Drug-Induced Liver Injury
    Hamilton, Leslie A.
    Collins-Yoder, Angela
    Collins, Rachel E.
    AACN ADVANCED CRITICAL CARE, 2016, 27 (04) : 430 - 440
  • [44] Drug-induced liver injury
    Grant, Lafaine M.
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (03) : 198 - 202
  • [45] A Case of Drug Induced Liver Injury
    Juhasz, Jason
    Khan, Rana
    Khan, Muhammad
    Goldenberg, Gregory
    Notar-Francesco, Vincent
    Bharathan, Thayyullathil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S278 - S279
  • [46] A Case of Drug Induced Liver Injury
    O'Sullivan, M.
    Quinn, S.
    Slattery, E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S201 - S201
  • [47] Drug induced liver injury: an update
    Miren Garcia-Cortes
    Mercedes Robles-Diaz
    Camilla Stephens
    Aida Ortega-Alonso
    M. Isabel Lucena
    Raúl J. Andrade
    Archives of Toxicology, 2020, 94 : 3381 - 3407
  • [48] Drug-induced liver injury
    Kaplowitz, N
    CLINICAL INFECTIOUS DISEASES, 2004, 38 : S44 - S48
  • [49] Drug-Induced Liver Injury
    Fisher, Kurt
    Vuppalanchi, Raj
    Saxena, Romil
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 876 - 887
  • [50] Drug-induced liver injury
    Kumachev, Alexander
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (20) : E746 - E747